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Abstract
Background: Studies on the feasibility of telepsychiatry tend to concentrate only on a subset of
clinical parameters. In contrast, this study utilises data from a comprehensive assessment. The main
objective of this study is to compare the accuracy of findings from telepsychiatry with those from
face to face interviews.
Method: This is a primary, cross-sectional, single-cluster, balanced crossover, blind study involving
new routine psychiatric referrals. Thirty-seven out of forty cases fulfilling the selection criteria went
through a complete set of independent face to face and video assessments by the researchers who
were blind to each other's findings.
Results: The accuracy ratio of the pooled results for DSM-IV diagnoses, risk assessment, non-drug
and drug interventions were all above 0.76, and the combined overall accuracy ratio was 0.81.
There were substantial intermethod agreements for Cohen's kappa on all the major components
of evaluation except on the Risk Assessment Scale where there was only weak agreement.
Conclusion: Telepsychiatric assessment is a dependable method of assessment with a high degree
of accuracy and substantial overall intermethod agreement when compared with standard face to
face interview for new routine outpatient psychiatric referrals.
Background
Verbal information and visual cues are major and primary
ingredients of psychiatric assessment. The sounds and
images transmitted through video-conferencing are equiv-
alent to these two parameters respectively. Other factors
such as empathy and rapport are also crucial and their
influence on the outcome of assessment is well under-
stood but not well quantified. The assumption that video-
conferencing would provide results equivalent to those
from face-to-face psychiatric interview is related to these
corollaries and requires testing and quantification. Trust
and confidence in using this technology can be greatly
enhanced if this assumption is proved true. In view of
rapid developments in hardware, wireless technology and
data-transmission, psychiatric intervention through
video-conferencing (telepsychiatry) can be an effective
mode of service delivery, especially for remotely located
population clusters.
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Meeting mental health needs for remotely and sparsely
populated communities has been a challenge to service
providers due to various factors including resource con-
strains and difficulty in recruitment of mental health staff.
Attempts have been made to address these concerns
through the use of new and emerging technologies. When
such new methods are used for clinical assessment, there
is bound to be inherent uncertainties as to whether these
new methods are as reliable, sensitive and accurate as
existing methods of clinical assessment.
Although several studies [1-4] can be found on pilot
projects and the feasibility of telepsychiatry, it seems that
to date none have attempted to test a predetermined
hypothesis for a complete set of clinical parameters in
adult psychiatry. Earlier reviews [5-7] were complemented
by evaluation of psychiatric assessment using the teleph-
ony system [8], video recording [9] and then video-con-
ferencing [10,11]. A recent study [12] demonstrated
usefulness of telepsychiatry as a valuable clinical and
research tool. However, most of these studies focussed
narrowly on the diagnostic aspect of psychiatric assess-
ment. Other studies have attempted to deal with psycho-
pathology [13,14], cost and feasibility [15,16], user
satisfaction [3,17], acceptability [18] and psychological
intervention [19,20]. The authors of this study failed to
identify studies of reasonable quality on complete and
comprehensive assessments of new psychiatric referrals in
a general adult outpatient clinic.
This study attempts to detect the level of intermethod
agreement between telepsychiatric assessment and face-
to-face interview for routine new outpatient referrals to
the general adult psychiatric unit. It is anticipated that
there is a high level of agreement between conclusions
drawn from psychiatric interviews through video-confer-
encing (V) and the standard method of face-to-face psy-
chiatric assessment (S) for diagnosis, risk assessment and
clinical intervention. This study aims to test this assump-
tion.
Methods
Setting and participants
The study was conducted at Hawkes Bay Health Care,
which provides a National Health Service to the Hawkes
Bay and Chatham Island areas of New Zealand (NZ). The
study was approved by the Hawkes Bay Ethics Committee,
New Zealand. The sample consisted of consecutive new
adult psychiatric referrals to the Napier Community Men-
tal Health Team (NCMHT). They belonged to the 19 to 65
age group, were not under care of the NCMHT and had
not received care for any mental health issue from this
unit for a period of at least 6 months at the time of referral.
Cases requiring urgent assessment or home visit were
excluded.
In clinical practice, the outcome of the standard method
of face-to-face assessment (S) is always supposed to be
accurate. Accordingly, using method S as the gold stand-
ard, the results from V can be classified as 'accurate' if the
outcome is identical to that from S for a given attribute, or
as 'inaccurate' if there is disagreement between methods S
and V. For the purpose of this study, the accuracy ratio
(AR) is defined as the risk ratio (RR) between the accurate
outcomes of video-assessment (V) and the results from
face-to-face assessment (S). Assuming an AR of 0.95 or
above for face-to-face assessment and results of video-
assessment at a significance level of 0.05 and a power of
0.8, a sample size of 34 for each method would suffice to
detect a difference of 15% or more between these two
methods of assessment [21]. Accordingly, a sample of 40
participants based on single stage cluster sampling was
considered to be adequate for this two-way, within sub-
jects, crossed balanced design. The data derived from this
study was also used for calculation of Cohen's kappa (CK)
and its bootstrap confidence interval.
From the 40 consecutive new psychiatric referrals fulfill-
ing above criteria, two cases declined to participate and
one case could not be located. A written informed consent
was obtained from all remaining 37 cases and they all
went through their complete intended assessments. The
referral period extended from 26 February 2001 to 15 May
2001 and the assessments were completed between 23
March 2001 and 17 May 2001.
Assessment procedure
The assessment order for each method and for each psy-
chiatrist was predetermined using a method of random
allocation. The whole list was randomly divided into the
two sub-lists, then participants were randomly allocated
to have their first assessment either by researcher R1 or R2.
The randomly selected half of the cases of each researcher
(R1 and R2) had their first assessment by method S and
the remaining half had their first assessment by method V.
The second assessment (S or V as appropriate) of each
individual case was subsequently completed by the other
researcher (R1 or R2). The details of the randomisations
and assessment procedures have been displayed in the
Figure 1.
None of the researchers had prior experience of conduct-
ing formal telepsychiatric interviews for clinical care. Prior
to initiating the research assessments, the researchers
spent one session to familiarise with the equipment, and
two sessions practising on known cases to evaluate and
compare their findings in order to enhance their interrater
agreement.
All face-to-face interviews were conducted at Hastings,
while video assessment was carried out from Wairoa, 140BMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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km away. All participants underwent both methods of
assessment; each participant having one assessment on
video by one psychiatrist and one face-to-face interview
by the other psychiatrist. The interviewers utilised their
own usual practice of clinical interview to resemble a
standard outpatient setting.
The main confounding variables likely to influence the
level of agreement are; bias between the researchers doing
the assessments, duration of interview, use of interpreter,
order-effect (effect on the second interview due to practice
or residual memory from the first interview) and the time
interval between the two methods of interview. The influ-
ence of such biases was minimised by adopting a crosso-
ver design and assigning an equal number of cases to each
of the interviewing psychiatrists, to each interview meth-
ods, and to each order of assessments (S followed by V
and V followed by S). The researchers were not aware of
each others findings while assessing an individual partici-
pant. Both assessments for each participant were com-
pleted on the same date and each assessment lasted up to
60 minutes. If an interpreter was involved, he/she had to
attend both sessions for that given case.
Video-Conferencing Units were available at Wairoa and
Hastings. Both centres were equipped with a PictureTel
Venue 2000 model 50 with 29 inch colour TV and were
linked with a 384 KB (128 KB × 3) bandwidth ISDN line.
Scanning and zooming of each of these video-conferenc-
ing units could be remotely controlled by the interviewer
or by the interviewee. The Picture-in-picture (PIP) facility
The sample randomisation Figure 1
The sample randomisation. The numbers in the boxes are the serial numbers of the sample cases. Those crossed are drop-
outs.
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was not used on the interviewee side to prevent unneces-
sary distraction during the interview.
Diagnostic tools, scales and data
Diagnoses on the DSM-IV axes were based on the method
described in the Decision Trees for Differential Diagnosis
of the Handbook [22] with assistance from the manual
when required. A Risk Assessment Schedule (RAS) was
adopted from the guidelines for assessment of risk factors
identified by the NZ Ministry of Health [23]. This scale
has not been tested for its reliability and validity and is
included in the appendix for information [Appendix-I]. A
List of Psychiatric Intervention (LIPI, Appendix-II) was
developed to record options of admission/discharge/fol-
low up, investigations, psychological intervention and
community support. Primarily, this is a list of clinical
decisions to select if applicable. The details of any phar-
macological intervention were also recorded in a struc-
tured format.
The full diagnostic code for the DSM-IV-Axis-1, the pres-
ence or absence of diagnoses on Axis2 and Axis-3, the
applicability or non-applicability of DSM-IV-Axis-4 ques-
tions and the score for DSM-IV-Axis-5 Global Assessment
of Functioning (GAF) was recorded for each assessment.
To confer uniformity, the numerical score of GAF was
changed into ordinal type ranging from lower to high cat-
egories (A to E) based on a class interval method fulfilling
the transformation criteria [24]. The RAS original scoring
options of 'NIL' and 'LOW' were merged to 'low', and
'HIGH' and 'VERY HIGH' to 'serious'. This produced three
distinct 'low', 'medium' and 'serious' risk categories for the
purpose of statistical analysis. Possible responses for items
of LIPI scale were dichotomous in nature excepting drug-
related outcomes. Clinical decisions for investigations,
psychological intervention and community support were
summarised on a group wise basis. All medications were
classified into nine types for eleven indications, resulting
in five drug related initiatives.
Minor adjustments were made to present the data table in
an n-by-n format as a pre-requisite for kappa calculation.
One DSM-IV Axis-1 diagnosis of disorganised schizophre-
nia (V, 295.10) was changed to paranoid schizophrenia
(295.30) giving a concordant entry; one case of
cyclothymic disorder, (S, 301.13) was changed to bipolar
disorder (296.56) giving a discordant entry; and one case
of factitious disorder (V, 300.16) was changed to somato-
form disorder (300.81) giving a concordant pair.
If the number of total diagnoses for a given case differed
between methods of assessment, a category of 'NIL' was
introduced to reflect the lack of identification of an equiv-
alent diagnosis by the corresponding method. This led to
the introduction of 2 concordant pairs and one discordant
pair by the first method of adjustment and 3 discordant
pairs arising from 'NIL' categories from the second
method of adjustment. The resulting preponderance of
discordant pairs over concordant pairs is likely to influ-
ence the interpretation against the research hypothesis,
rather than in favour of it.
Statistical evaluation
The test statistics of AR, Risk Difference (RD) and CK were
calculated and summarised in accordance with methods
described in the standard texts [24-26]. For the purpose of
comparisons using AR and RD, an assumption is made
that all outcomes from face-to-face assessment are 100%
accurate. While using the asymptotic method of computa-
tion, some of the upper confidence interval of CK may
exceed the permitted value of 1. Techniques like Bias Cor-
rected Accelerated Bootstrap Confidence Interval (BCaCI)
[27] and exact p estimate [28] have been advocated to
resolve this paradox. Accordingly, this study applied non-
parametric BCaCI methodology using 50,000 bootstrap
samples with replacement.
The re-sampling was performed in a manner that retained
the structural consistency of each subgroup. The tech-
niques of bootstrapping and re-sampling are well estab-
lished statistical methods and yet are little known in
medical literature. The required software codes were
developed for these models by the principal author (SPS)
using R (version 2.4.1) [29] and were tested against other
packages (SPSS, SAS and S-Plus) before data analysis. R is
an open source statistical language software from the R
Foundation of Statistical Computing, Vienna (ISBN 3-
900051-07-0, 2006).
Results
Of 37 participants, 20 were female and 17 male. Ethni-
cally, there were 27 participants of European descent, 8
were of Maori origin and 2 were from other groups. Their
ages ranged between 19.21 and 63.29 years; with an aver-
age age of 35.40 years and a standard deviation of 12.46
years.
The presence of statistical significance for the results of
ARs in the Table 1 is based on two sided p value of 0.05 or
less. The primary data from rows 1 to 30 in Table 1 and
from rows 1 to 28 in Table 2 have been re-used to summa-
rise in the remaining rows of their respective tables. This
has invariably lead to multiple comparisons and interpre-
tation of the results should reflect this limitation.
The ARs (Table 1) with nil variance (rows 6, 8, 10) were
excluded from comparison due to the constant nature of
observation data. The results with upper 95% confidence
interval of AR>1 (rows 2, 3, 7, 11, 19, 24) were not treated
as statistically significant due to the fact that the accuracyBMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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Table 1: Comparison of results of telepsychiatric assessments and face-to-face interviews
Sample Accuracy Ratio Statistics Risk Difference Statistics
Primary attributes and accuracy
A I Size AR LCI UCI p RD LCI UCI p
01 DSM-IV Axis 1 49 5 54 0.91 0.83 0.99 0.025 -0.09 -0.17 -0.02 0.019
02 DSM-IV Axis 2 34 3 37 0.92 0.84 1.01 0.083 -0.08 -0.17 0.01 0.071
03 DSM-IV Axis 3 36 2 38 0.95 0.88 1.02 0.157 -0.05 -0.12 0.02 0.146
04 DSM-IV Axis 4 Q1 31 6 37 0.84 0.73 0.97 0.014 -0.16 -0.28 -0.04 0.007
05 DSM-IV Axis 4 Q2 31 6 37 0.84 0.73 0.97 0.014 -0.16 -0.28 -0.04 0.007
06 DSM-IV Axis 4 Q3 37 0 37 1.00 1.00 1.00 NA 0.00 0.00 0.00 NA
07 DSM-IV Axis 4 Q4 36 1 37 0.97 0.92 1.03 0.317 -0.03 -0.08 0.03 0.311
08 DSM-IV Axis 4 Q5 37 0 37 1.00 1.00 1.00 NA 0.00 0.00 0.00 NA
09 DSM-IV Axis 4 Q6 32 5 37 0.86 0.76 0.98 0.025 -0.14 -0.25 -0.02 0.016
10 DSM-IV Axis 4 Q7 37 0 37 1.00 1.00 1.00 NA 0.00 0.00 0.00 NA
11 DSM-IV Axis 4 Q8 34 3 37 0.92 0.84 1.01 0.083 -0.08 -0.17 0.01 0.071
12 DSM-IV Axis 4 Q9 1 36 37 0.03 0.00 0.19 0.000 -0.97 -1.03 -0.92 0.000
13 DSM-IV Axis 5 26 11 37 0.70 0.57 0.87 0.001 -0.30 -0.44 -0.15 0.000
14 Risk to Self Q1 27 10 37 0.73 0.60 0.89 0.002 -0.27 -0.41 -0.13 0.000
15 Risk to Self Q2 29 8 37 0.78 0.66 0.93 0.005 -0.22 -0.35 -0.08 0.001
16 Risk to Self Q3 28 9 37 0.76 0.63 0.91 0.003 -0.24 -0.38 -0.10 0.001
17 Risk to Self Q4 28 9 37 0.76 0.63 0.91 0.003 -0.24 -0.38 -0.10 0.001
18 Risk to Others Q1 28 9 37 0.76 0.63 0.91 0.003 -0.24 -0.38 -0.10 0.001
19 Risk to Others Q2 35 2 37 0.95 0.88 1.02 0.157 -0.05 -0.13 0.02 0.146
20 Risk to Others Q3 33 4 37 0.89 0.80 1.00 0.046 -0.11 -0.21 -0.01 0.034
21 Risk to Others Q4 32 5 37 0.86 0.76 0.98 0.025 -0.14 -0.25 -0.02 0.016
22 Risk to Others Q5 33 4 37 0.89 0.80 1.00 0.046 -0.11 -0.21 -0.01 0.034
23 Risk to Others Q6 29 8 37 0.78 0.66 0.93 0.005 -0.22 -0.35 -0.08 0.001
24 Admit-Discharge-Follow-up 34 3 37 0.92 0.84 1.01 0.083 -0.08 -0.17 0.01 0.071
25 Investigations 25 12 37 0.68 0.54 0.84 0.001 -0.32 -0.48 -0.17 0.000
26 Psychological Input 26 11 37 0.70 0.57 0.87 0.001 -0.30 -0.44 -0.15 0.000
27 Community Support 29 8 37 0.78 0.66 0.93 0.005 -0.22 -0.35 -0.08 0.001
28
Drug Type
64 11 75 0.85 0.78 0.94 0.001 -0.15 -0.23 -0.07 0.000
29
Drug Action
58 17 75 0.77 0.68 0.87 0.000 -0.23 -0.32 -0.13 0.000
30
Drug Indication
49 26 75 0.65 0.55 0.77 0.000 -0.35 -0.45 -0.24 0.000
Main Attributes
31
DSM-IV Axis 1 (1)
49 5 54 0.91 0.83 0.99 0.025 -0.09 -0.17 -0.02 0.019
32 DSM-IV Axis 2 (2) 34 3 37 0.92 0.84 1.01 0.083 -0.08 -0.17 0.01 0.071
33 DSM-IV Axis 3 (3) 36 2 38 0.95 0.88 1.02 0.157 -0.05 -0.12 0.02 0.146
34 DSM-IV Axis 4 (4:12) 276 57 333 0.83 0.79 0.87 0.000 -0.17 -0.21 -0.13 0.000
35 DSM-IV Axis 5 (13) 26 11 37 0.70 0.57 0.87 0.001 -0.30 -0.44 -0.15 0.000
36 Risk to Self (14:17) 112 36 148 0.76 0.69 0.83 0.000 -0.24 -0.31 -0.17 0.000
37 Risk to Others (18:23) 190 32 222 0.86 0.81 0.90 0.000 -0.14 -0.19 -0.10 0.000
38 Admit-Discharge-Follow-up (24) 34 3 37 0.92 0.84 1.01 0.083 -0.08 -0.17 0.01 0.071
39 Investigations (25) 25 12 37 0.68 0.54 0.84 0.001 -0.32 -0.48 -0.17 0.000
40 Psychological Input (26) 26 11 37 0.70 0.57 0.87 0.001 -0.30 -0.44 -0.15 0.000
41 Community Support (27) 29 8 37 0.78 0.66 0.93 0.005 -0.22 -0.35 -0.08 0.001
42 Drug Type (28) 64 11 75 0.85 0.78 0.94 0.001 -0.15 -0.23 -0.07 0.000
43 Drug Action (29) 58 17 75 0.77 0.68 0.87 0.000 -0.23 -0.32 -0.13 0.000
44 Drug Indication (30) 49 26 75 0.65 0.55 0.77 0.000 -0.35 -0.45 -0.24 0.000
Major Attributes
45 DSM Diagnosis (1:13) 421 78 499 0.84 0.81 0.88 0.000 -0.16 -0.19 -0.12 0.000
1
3
4
5
2BMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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46 Risks (14:23) 302 68 370 0.82 0.78 0.86 0.000 -0.18 -0.22 -0.14 0.000
47 Non-Drug Intervention (24:27) 114 34 148 0.77 0.71 0.84 0.000 -0.23 -0.30 -0.16 0.000
48 Drug Intervention (28:30) 171 54 225 0.76 0.71 0.82 0.000 -0.24 -0.30 -0.18 0.000
Overall
49 Overall Result (1:30) 10
08
23
4
1242 0.81 0.79 0.83 0.000 -0.19 -0.21 -0.17 0.000
A: Accurate outcome, I: Inaccurate Outcome, AR: Accuracy Ratio (Risk Ratio), LCI: Lower 95% Confidence Interval, UCI: Upper 95% 
Confidence Interval, RD: Risk Difference when the sample statistics compared with Accuracy (Risk) of 1 for the face-to-face interview. All 
approximated p values are more than zero.
Numbers in brackets represent index number of primary attributes serialised in the previous rows.
Drug Types- Atypical Antipsychotic, Mood Stabilizer, Tricyclic Antidepressant, Newer Antidepressant, Other Antidepressant, Benzodiazepine 
Group, Non-Benzodiazepine Anxolytic, Anti-Parkinsonian, and 'No Medication'.
Drug related actions were grouped into 'New Prescription', 'Continuation of previously prescribed medication with no change', and 'Adjustment 
of previously prescribed medication'.
Drug Indications were categorised for Positive Psychotic Symptoms, Manic symptoms, Bipolar Disorder, Depression, Anxiety and Associated 
Symptoms, Drugs for Side Effects (e.g. Anti-parkinsonian), Hypnotics, and Use of Drugs' sedative effect for anxiety control and sleep.
Table 1: Comparison of results of telepsychiatric assessments and face-to-face interviews (Continued)
1
2
3
4
5
Table 2: Cohen's Kappa results of intermethod and interviewers assessments
Standard vs Video Interviewers
SN Primary Attributes
Size Group CK LCI UCI CK LCI UCI
1 DSM-IV Axis 1 54 26 0.90 0.28 1.00 0.90 0.33 1.00
2 DSM-IV Axis 2 37 2 0.62 -0.04 0.87 0.63 0.21 0.87
3 DSM-IV Axis 3 38 2 0.84 0.49 0.93 0.84 0.49 0.93
4 DSM-IV Axis 4 Q1 37 2 0.57 0.25 0.82 0.57 0.22 0.83
5 DSM-IV Axis 4 Q2 37 2 0.17 -0.11 0.72 0.18 -0.09 0.68
6 DSM-IV Axis 4 Q3 37 2 0.85 0.66 0.91 0.85 0.66 0.91
7 DSM-IV Axis 4 Q4 37 2 0.87 0.65 0.94 0.87 0.65 0.94
8 DSM-IV Axis 4 Q5 37 2 0.66 NA NA 0.66 NA NA
9 DSM-IV Axis 4 Q6 37 2 0.55 0.18 0.84 0.54 0.13 0.84
10 DSM-IV Axis 4 Q8 37 2 0.36 -0.07 0.79 0.37 -0.08 0.54
11
DSM-IV Axis 5
37 5 0.89 0.81 0.94 0.89 0.81 0.94
12
Risk to self Q1
37 3 0.66 0.39 0.86 0.65 0.39 0.86
13
Risk to self Q2
37 3 0.68 0.34 0.86 0.68 0.37 0.86
14
Risk to self Q3
37 3 0.55 -0.11 0.73 0.55 0.22 0.80
15
Risk to self Q4
37 3 0.45 -0.11 0.68 0.45 0.12 0.79
16
Risk to others Q1
37 3 0.62 0.27 0.86 0.62 0.27 0.86
17
Risk to others Q2
37 3 0.82 0.30 1.00 0.82 0.37 1.00
18
Risk to others Q3
37 2 -0.04 -0.10 -0.03 -0.04 -0.10 -0.03
19
Risk to others Q4
37 3 0.55 -0.11 0.78 0.55 -0.06 0.78
20
Risk to others Q5
37 2 0.44 -0.07 0.84 0.44 -0.06 0.84
21
Risk to others Q6
37 3 0.41 -0.13 0.66 0.41 -0.12 0.66
22 Admit-Discharge-Follow up 37 3 0.76 0.37 0.93 0.76 0.37 0.93
1 2 3 4 4 3 4 4
5
5
5
5
5
5
5
5
5
5
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ratio cannot exceed a maximum value of 1. Using these
criteria, all the remaining observations of the 'primary
attributes' are both valid and statistically significant
between 0.65 and 0.91 excepting one of the items (row
12) in Axis 4 of the DSM. The pooled ARs for the main
attributes (rows 31, 34 to 37, and 39 to 44) and major
attributes (rows 45 to 48) are from 0.65 to 0.91 and from
0.76 to 0.84 respectively. The overall AR (row 49) for the
combined assessments is 0.81.
The criteria described in the previous paragraph were also
applied for RDs (Table 1). Accordingly, all the valid obser-
23 Investigations 37 2 0.29 -0.03 0.59 0.30 -0.02 0.59
24 Psychological Input 37 2 0.16 -0.17 0.53 0.18 -0.12 0.54
25 Community Support 37 2 0.55 0.22 0.78 0.56 0.25 0.78
26
Drug Type
75 9 0.83 0.61 0.90 0.82 0.52 0.90
27
Drug Action
75 5 0.67 0.52 0.79 0.66 0.52 0.79
28
Drug Indication
75 11 0.59 0.35 0.74 0.59 0.35 0.76
Main Attributes
29 DSM-IV Axis 1 (1) 54 26 0.90 0.28 1.00 0.90 0.33 1.00
30 DSM-IV Axis 2 (2) 37 2 0.62 -0.04 0.87 0.63 0.21 0.87
31 DSM-IV Axis 3 (3) 38 2 0.84 0.49 0.93 0.84 0.49 0.93
32 DSM-IV Axis 4 (4:10) 259 14 0.65 0.52 0.78 0.65 0.52 0.78
33 DSM-IV Axis 5 (11) 37 5 0.89 0.81 0.94 0.89 0.81 0.94
34 Risk to self (12:15) 148 12 0.61 0.48 0.75 0.61 0.48 0.75
35 Risk to Others (16:21) 222 16 0.05 -0.01 0.11 0.05 -0.01 0.11
36 Admit-Discharge-Follow up 
(22)
37 3 0.76 0.37 0.93 0.76 0.37 0.93
37 Investigations (23) 37 2 0.29 -0.03 0.59 0.30 -0.02 0.59
38 Psychological Input (24) 37 2 0.16 -0.17 0.53 0.18 -0.12 0.54
39 Community Support (25) 37 2 0.55 0.22 0.78 0.56 0.25 0.78
40 Drug Type (26) 75 9 0.83 0.61 0.90 0.82 0.52 0.90
41 Drug Action (27) 75 5 0.67 0.52 0.79 0.66 0.52 0.79
42 Drug Indication (28) 75 11 0.59 0.35 0.74 0.59 0.35 0.76
Major Attributes
43 DSM-IV (1:11) 425 49 0.86 0.81 0.90 0.86 0.81 0.90
44 Risks (12:21) 370 28 0.14 0.08 0.19 0.14 0.09 0.19
45 Non-Drug Intervention 
(22:25)
148 9 0.49 0.35 0.64 0.49 0.35 0.64
46 Drug Intervention (26:28) 225 25 0.72 0.66 0.79 0.72 0.66 0.79
Overall
47 Overall Result (1:28) 1168 111 0.60 0.57 0.63 0.60 0.57 0.63
The column 'Size' constitutes the number of total sample points used for assessments.
The column 'Group' stands for the number of total categories of results e.g. all diagnoses with Paranoid Schizophrenia will make one group.
CK: Cohen's Kappa values derived from 'n by n' table made from the Groups. The significant values (Lower CI more than 0) are printed in bold. 
The summary CK results in the rows from 29 to 47 are based on "Inverse Variance method" using CKs and variances from previous rows displayed 
in the brackets for the respective assessments.
95% Lower & Upper Confidence Intervals (LCI and UCI) from the rows 1 to 28 are derived from non-parametric Bias Corrected Accelerated 
(BCa) variance from 50,000 bootstrap samples with replacement. The summary LCIs and UCIs in the rows from 29 to 47 are based on "Inverse 
Variance method" using CKs and original variances from previous rows are displayed in the brackets for the respective assessments.
Weighted Kappa using "square error weights" were computed for ordinal observations where applicable.
The definitions for Drug Type, Drug Action and Drug Indication are same as in the Table 1.
Table 2: Cohen's Kappa results of intermethod and interviewers assessments (Continued)
6
6
6
1
2
3
4
5
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Table 3: 
RAS (Risk Assessment Schedule)
Enter the RISK in terms of NIL, LOW, MEDIUM, HIGH & VERY HIGH Risk.
MENTAL STATE (RAS – 1) N L M H V
Behaviour
• Dangerous or threatening actions N L M H V
• Verbal/non-verbal risks N L M H V
• Deliberate self harm N L M H V
• Aggression NLM HV
Affect
• Arousal, anger, hostility, irritability, suspiciousness, fear N L M H V
• Low mood or elevated mood N L M H V
Cognition
• Fantasies of deliberate self harm or harm to others N L M H V
• Persecutory thoughts, delusions N L M H V
• External control N L M H V
• Confusion NLM HV
• Preoccupation, obsession, jealousy N L M H V
• Control over-ride N L M H V
• Cultural beliefs N L M H V
Perceptions
• Command hallucinations N L M H V
• Misidentification N L M H V
• Matakite NLM HV
ENVIRONMENTAL/CURRENT FACTORS (RAS – 2) N L M H V
Immediate stressors
• Substance use, intoxication or withdrawal N L M H V
• Relationships NLM HV
• Presence or absence of support N L M H V
• Absence of treatment, non compliance N L M H V
• Persecution or threats from others N L M H V
• Arrest or criminal charges N L M H V
• Loss including death of a peer N L M H V
• Cultural transgression N L M H V
• Financial stress N L M H V
Access
• To weapons, pills, victims N L M H V
Situation
• Referral from Prison, Police, Secure Unit N L M H V
Individual's attitude
• Co-operation N L M H V
• Refusal to co-operate or fear of compulsory treatment N L M H V
HISTORICAL INFORMATION (RAS-3) N L M H V
Illness and incidents
• Patterns of illness – Chronic active, Neurological disorder, H/O Head injury N L M H V
• Psychiatric history – Serious mental illness, Multiple diagnoses, Treatment under MHA N L M H V
• History of incidents (and context) – Repeated antisocial behavior N L M H V
• Treatment and outcomes – Compliance and response of treatment given in past N L M H VBMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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vations excluding DSM-IV Axis 4 Q9, range between -0.35
and -0.09 and are statistically significant. There is an over-
all accuracy difference of -0.19, with 95% confidence
interval between -0.21 and -0.17. This result supports a
hypothesis that overall outcome of telepsychiatric assess-
ment is about 19% inferior to face-to-face interview.
Table 2 has observation data about agreements between
the two methods of interview and between the interview-
ing psychiatrists. There is trend to classify CK values ≤ 0 as
poor, those from 0.01 to 0.20 as slight, from 0.21 to 0.40
as fair, from 0.41 to 0.60 as moderate, from 0.61 to 0.80
as substantial and from 0.81 to 1 as perfect [30]. From a
total of 27 valid primary attributes (rows 1 to 28), 16 have
moderate to substantial statistically significant inter-
method BCa Kappa values. Similarly, 10 of 14 main
attributes (rows 29 to 42) have agreements at moderate to
substantial level.
The Kappa scores for intermethod agreement of DSM Axes
(rows 29 to 33) varied from substantial (0.65) to perfect
(0.90) excepting axis 2, where the result was not statisti-
cally significant. The agreement was perfect (0.86) for
combined DSM categories (row 43). The overall Kappa
score for risk (row 44) was only slight, though it was sub-
stantial in respect of assessment of 'risk to self' (row 34).
Agreement levels for investigations and psychological
input (rows 23 and 24) were non-significant while that
for Community Support (row 25) was moderate (0.55).
There was moderate agreement (0.49) on non-drug inter-
vention as a whole (row 45). Various components of Drug
Treatment (rows 26 to 28) had agreement levels between
high moderate (0.59) to perfect (0.83) with substantial
rating (0.72) as a whole (row 46). Overall agreement
between the telepsychiatric assessments and face-to-face
interviews for the completed psychiatric assessments
reached a downward approximated value of 0.60, hence it
was substantial.
The interrater agreements between the two interviewing
psychiatrists were very close and could not be differenti-
ated from that of intermethod assessment. Their respec-
tive values do not differ more than 0.01, with a
considerable degree of overlap between their confidence
intervals. Accordingly, there is no significant difference
between intermethod and interrater agreements and are
equivalent to each other.
• Features of past crises – Pathological intoxication, Episodic dyscontrol, Cruelty to 
animals, Blackouts
NLM HV
• Personal history – Criminal charges, Previous offenses, Forensic involvement N L M H V
Personality
• Usual coping style – Loner, Displaced rage reaction, self mutilism, Impulsivity, denial, 
Blaming others
NLM HV
Family background
• Demographics – Single, Male, Poor, Low educational and vocational success N L M H V
• Culture – Tolerance to antisocial behavior, Reluctance to disclose, Shame & Guilt N L M H V
• Dynamics – H/O Violence, Contact of violent gangs, Intrafamilial violence N L M H V
OUTCOME OF RISK ASSESSMENT
(Use knowledge & Information gathered from RAS-1, 2 & 3)
RISK TO SELF N L M H V
1. Safety (including suicidal acts, deliberate self harm) N L M H V
2. Health (incl. drug & alcohol abuse, physical & psychological harm) N L M H V
3. Self neglect and vulnerability (incl. exploitation, sexual abuse, violence from others) N L M H V
4. Quality of life (including dignity, social and financial status) N L M H V
RISK TO OTHERS N L M H V
1. Violence (including emotional, sexual and physical violence)
2. Intimidation/threats N L M H V
3. Neglect/abuse of Dependants N L M H V
4. Stalking/harassment N L M H V
5. Reckless behavior (including driving)Property damage (including arson) N L M H V
6. Public nuisance N L M H V
Table 3:  (Continued)BMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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Discussion
This study aims to establish whether conclusions drawn
from telepsychiatric assessments are in agreement with
those from the standard method of face-to-face assess-
ment for new referrals in an outpatient clinic. Most new
and old referrals to the Community Mental Health Teams
in the UK and NZ are discussed in a multidisciplinary
team setting. Application of DSM diagnostic criteria in NZ
has gradually evolved into standard clinical practice and is
becoming popular in the UK. The application of Decision
Tree for diagnosis on Axis-1 of DSM-IV can be easily
adopted without significant additional resources and
training. The methodology adopted in this study emulates
the real clinic situation; hence its findings are both appli-
cable and relevant to day-to-day clinical practice.
The authors have taken all necessary precautions in deal-
ing with anticipated results, some of which might be par-
adoxical or erroneous e.g. CK and AR exceeding a
maximum permitted value of 1. Those results where AR>1
and with nil variance were excluded from further statisti-
cal interpretation. Though the number of studied cases
was only 37, the numbers of sample points (as in 'Size'
column of Table 1) for statistical calculation were large
enough for meaningful interpretation. The issue of sam-
ple size in handling large number of diagnostic categories
for CK was dealt with bootstrapping technique and non-
parametric Bias Corrected Accelerated Bootstrap Confi-
dence Interval. This approach enhances the statistical
quality of the data analysis.
A previous study [5] evaluating twelve telepsychiatric and
face-to-face assessments on multiple scales found a mean
weighted kappa coefficient of 0.85. The interrater reliabil-
ity for diagnosis between two psychiatrists in three differ-
ent experimental conditions on 63 patients has been
found to vary between 0.69 and 0.85 [6]. A review of tel-
epsychiatry services in Australia concluded that this tech-
nology could be reliably used for treatment
recommendations and diagnostic assessments [7]. A
Canadian study involving child psychiatrists found that in
96% of cases, the diagnosis and treatment recommenda-
tions made via video-conferencing were identical to those
made in face-to-face interviews [10]. Another study [8]
using telecommunication and audiovisual technology
found interrater diagnostic agreement of 0.70. Despite
methodological differences, the results from the present
study are consistent with the findings quoted above in this
paragraph.
Interrater agreement among clinicians for video-taped
face-to-face interviews has been noted to have a relatively
lower CK value of 0.55 [9]. It is possible that the flexibility
conferred by the ability to question the patient in real time
in a face-to-face or video-conferencing interview is an
advantage over videotape assessment and accounting for
improved intermethod and interrater agreement.
In a field trial of DSM-III, the interrater reliability for face-
to-face interviews for the major disorders varied between
Table 4: LIST OF PSYCHIATRIC INTERVENTION (LIPI)
Admission/Discharge/Followup (LIPI-1):
Admission
Discharge
Followup
Investigations (LIPI-2):
Haematological
Biochemical
Serum Level of Medication
ECG tests
EEG Examination
CT/NMRI/PET/Isotope/Ultrasound
IQ Assessment
Other biological test
Other Psychological Tests
Psychological Intervention (LIPI-3):
Investigation
Simple Explanations
Support & Advice
Self Help by Book
Self Help Group
Assertiveness Training
Anger Control
Domestic Skills Training
Budget Handling Training
Social Skill Training
Counselling
Marital Therapy
Divers ional Therapy
Relaxation Training
Paper bag Ventilation
Systemic Desensitisation
Biofeedback
Cognitive Behaviour Therapy
Psychotherapy
Family Therapy
Other
Community Support (LIPI-4):
Intervention
CPN visit to support patient
CPN visit to support family
Activity Therapy (Gym, sports etc)
Handling Bills and Finances
Helping in making Applications to other agencies
Outreach
Home Help
Meals on Wheels
Art & Work therapy (Art, wood, gardening)
Day Hospital for socialisation
LIPI-5: Information related to Drug Type, Action and Indication 
scored in different tableBMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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kappa values of 0.28 to 0.92 [31] and an another study on
ICD-10 also yielded a fair to good kappa values for the
four-character diagnostic codes [32]. In comparison, the
outcome of telepsychiatric assessments in the current
study is at least similar to the interrater reliability of face-
to-face interviews from these large field trials.
None of the primary studies quoted above tested inter-
method agreement for a complete set of clinical parame-
ters. Their sample size and statistical methodology are
also limiting factors for satisfactory conclusions. In con-
trast, the present study employs suitable statistical meth-
ods for comprehensive outpatient assessment for multi-
axial DSM-IV diagnosis, risk assessment, investigations,
and treatment. As compared to standard method of face-
to-face interviews, telepsychiatric assessments in this
study have a high accuracy ratio (AR 0.81) and a substan-
tial intermethod agreement (CK 0.60).
Although the kappa value of intermethod agreement for
risk assessment is low, it would be premature to ascribe
this to telepsychiatric assessment itself. A study on video-
taped interviews of 30 patients attending emergency psy-
chiatry service revealed interrater correlation coefficients
of 0.32 and 0.44 for risks to self and others respectively
[33]. Another study conducted in a comparable setting
also found similar results and came with the observation
that in some circumstances the level of disagreement was
high enough to warrant concern [34]. In a prospective
study for risk assessment on 161 inmates of a high risk
forensic unit [35] the agreement level among psychiatrists
for face-to-face interviews in absence of operational crite-
ria was very poor (CK -0.006). The same study reported
that this agreement can be greatly enhanced (CK 0.742)
by application of operational criteria. The findings in the
present study for risk assessment are comparable to these
results. In addition, the lower base level of risk in routine
outpatient clinics in comparison to emergency and foren-
sic psychiatric units is likely to cause further decrement in
the kappa level.
There is a paucity of research-based knowledge concern-
ing levels of agreement for risk factors. Most of the scales
currently used for risk-assessments have yet to have their
reliability, validity and predictability ascertained. To
establish agreement levels in statistical terms for uncom-
mon risk elements (suicides and homicides etc.) would
require an enormous sample which may not be feasible.
Lack of a valid and reliable tool for risk assessment may
produce erroneous results while uncertainty over the time
frame (short-term, immediate and long-term) for risk
anticipation may lead to inconsistencies in reporting and
recording. The sort-term serious risk will probably be
dealt with in the emergency system rather than through
routine outpatient referrals and the long-term risks are
likely to have minimal influence on the decision making
process while dealing with routine outpatient referrals.
The ability to reach an accurate DSM-IV-Axis-1 diagnosis
through telepsychiatric assessment is perfect (CK 0.90)
and accurate (AR 0.91). Arriving at a reasonable diagnos-
tic impression is a pre-requisite of the medical recommen-
dation for assessment or treatment under the Mental
Health Act and this objective can be very well achieved
through telepsychiatry. Another prerequisite under the act
is to evaluate potential risks with input and information
from various sources. Identification of risk related con-
cerns direct from the interviewee constitutes only one
component of this whole process. The referring agency
usually indicates and expresses its concerns about risk ele-
ments and additional information are generally obtained
on telephone from other sources such as clinicians and
family members. With this in mind, low concordance on
risk assessment may not necessarily be a limiting factor in
the use of telepsychiatry for the purpose of Mental Health
Act assessment.
Conclusion
Telepsychiatry is a dependable mode of service delivery
for diagnostic assessment and psychiatric intervention in
routine new referrals. Its accuracy varies between 79% and
83% in comparison with face-to-face interview. There is
also an overall substantial agreement between these two
methods of psychiatric evaluation. Although there is
potential for usage of telepsychiatry for the Mental Health
Act assessment, this requires further research using more
refined operational tools to enhance the low accuracy and
agreement scores found in the present study. The accuracy
of conclusions arrived at from telepsychiatric assessment
is likely to improve in future with further advances in
technology [36].
Clinical implications
1. Allows telepsychiatric services to be made available to a
geographically distant and inaccessible population where
it is difficult and expensive to recruit mental health profes-
sionals.
2. Enhances confidence in use of telepsychiatry as an alter-
native mode of service delivery.
3. Increases scope of international research and collabora-
tion in the practice of clinical psychiatry in different parts
of the world.
Limitations and solutions
1. Although the outcome of risk assessment was similar to
other studies, the level of agreement for this parameter is
significantly low. There is scope to overcome this deficit
through usage of operational criteria [35]. On this subject,BMC Psychiatry 2007, 7:55 http://www.biomedcentral.com/1471-244X/7/55
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some of the scientifically unexplored topics such as tools
for risk assessment, its reliability and predictive value
require further research.
2. The study assumed that there is 100% concordance
between clinical decisions amongst psychiatrists if they
conduct face-to-face interviews. This is seldom the case.
Further studies with an added component to detect over-
all interrater agreement for face-to-face assessment will
help in eliminating the need for this hypothetical 100%
concordance rate.
3. There is an inherent problem in determining the sam-
ple size for CK for an unknown number of categories that
may be encountered during a prospective research. This
requires application of alternative statistical approaches.
The current study has attempted to address some of these
concerns through usage of resampling method and boot-
strap confidence intervals.
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